DocSym
β
Searchsearch
Search
(C49.6) Malignant neoplasm: connective and soft tissue of trunk, unspecified
More details coming soon
1 149 259 in individuals diagnosis malignant neoplasm: connective and soft tissue of trunk, unspecified confirmed
167 528 deaths with diagnosis malignant neoplasm: connective and soft tissue of trunk, unspecified
15% mortality rate associated with the disease malignant neoplasm: connective and soft tissue of trunk, unspecified
Diagnosis malignant neoplasm: connective and soft tissue of trunk, unspecified is diagnosed Men are 7.22% more likely than Women
616 093
Men receive the diagnosis malignant neoplasm: connective and soft tissue of trunk, unspecified
82 864 (13.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
533 166
Women receive the diagnosis malignant neoplasm: connective and soft tissue of trunk, unspecified
84 664 (15.9 %)Died from this diagnosis.
Risk Group for the Disease malignant neoplasm: connective and soft tissue of trunk, unspecified - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features malignant neoplasm: connective and soft tissue of trunk, unspecified
Absence or low individual and public risk
Malignant neoplasm: connective and soft tissue of trunk, unspecified - what does this mean
Malignant neoplasm of connective and soft tissue of the trunk is a cancerous tumor that develops in the tissues that support, connect, or surround other structures and organs in the trunk. it is usually caused by an uncontrolled growth of abnormal cells that can invade and damage nearby tissues and spread to other parts of the body.
What happens during the disease - malignant neoplasm: connective and soft tissue of trunk, unspecified
Malignant neoplasm of connective and soft tissue of trunk, unspecified is caused by the uncontrolled growth of abnormal cells in the connective and soft tissue of the trunk. this growth is caused by genetic mutations that can be inherited or acquired through exposure to environmental factors such as radiation or certain chemicals. the abnormal cells grow and divide rapidly, forming a mass that can invade and damage nearby tissue. the mass can also spread to other parts of the body.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Obtain medical history and review of systems
- Physical examination
- Imaging tests such as X-ray, CT scan, MRI, and PET scan
- Biopsy
- Blood tests
- Urine tests
- Endoscopy
- Ultrasound
Treatment and Medical Assistance
Main goal of the treatment: To reduce the spread of the malignant neoplasm and to improve the patient's quality of life.
- Surgery to remove the tumor
- Radiation therapy to target cancer cells
- Chemotherapy to target cancer cells
- Immunotherapy to boost the immune system
- Targeted therapy to inhibit cancer growth
- Hormone therapy to reduce the growth of cancer cells
- Rehabilitation to improve physical and psychological functioning
- Pain management to reduce discomfort
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neoplasm: connective and soft tissue of trunk, unspecified - Prevention
The best way to prevent malignant neoplasms of the connective and soft tissue of the trunk is to maintain a healthy lifestyle: eating a balanced diet, exercising regularly, avoiding smoking and excessive alcohol consumption, and getting regular check-ups from a qualified medical professional. additionally, it is important to be aware of any changes in the appearance or texture of the connective and soft tissue of the trunk, and to seek medical attention if any changes are noticed.